Jiangsu Biojetay Biotechnology Co., Ltd.

This study is testing whether an experimental injection called STSP-0601 can effectively stop bleeding episodes in people with hemophilia A or B who have developed inhibitors. The trial involves 32 participants aged 12-70 who experience frequent bleeding episodes despite standard…

This study is testing a new injectable drug called STSA-1301 for people with a chronic immune disorder that causes low platelet counts (ITP). The main goals are to check if the drug is safe and to see if it can help raise and maintain platelet levels. It will involve both healthy…